Captrust Financial Advisors Ligand Pharmaceuticals Inc Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 12,222 shares of LGND stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,222

Previous 12,629 3.22%

Holding current value

$1.36 Million

Previous $1.06 Million 15.04%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$82.7 - $110.11 $33,658 - $44,814	-407 Reduced 3.22%	12,222 $1.22 Million
Q2 2024 Aug 14, 2024	BUY	$68.53 - $87.91 $405,149 - $519,723	5,912 Added 88.02%	12,629 $1.06 Million
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $27,593 - $35,858	402 Added 6.37%	6,717 $491,000
Q4 2023 Feb 14, 2024	BUY	$49.57 - $72.63 $16,358 - $23,967	330 Added 5.51%	6,315 $451,000
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $352,277 - $434,929	5,985 New	5,985 $358,000
Q2 2022 Aug 23, 2022	SELL	$74.52 - $117.06 $1,192 - $1,872	-16 Reduced 1.74%	902 $80,000
Q2 2022 Aug 16, 2022	BUY	$74.52 - $117.06 $1,937 - $3,043	26 Added 2.91%	918 $82,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $42,270 - $67,444	-445 Reduced 33.28%	892 $100,000
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $21,962 - $28,526	-172 Reduced 11.4%	1,337 $207,000
Q3 2021 Nov 16, 2021	BUY	$102.33 - $144.73 $3,581 - $5,065	35 Added 2.37%	1,509 $210,000
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $113 - $155	-1 Reduced 0.07%	1,474 $193,000
Q1 2021 May 17, 2021	BUY	$99.52 - $215.83 $135,048 - $292,881	1,357 Added 1150.0%	1,475 $225,000
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $402 - $530	5 Added 4.42%	118 $12,000
Q3 2020 Nov 17, 2020	SELL	$89.56 - $126.72 $42,093 - $59,558	-470 Reduced 80.62%	113 $11,000
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $71,625 - $129,708	-1,049 Reduced 64.28%	583 $65,000
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $103,419 - $176,060	1,632 New	1,632 $111,000
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $36,061 - $42,255	-372 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$107.38 - $129.34 $4,295 - $5,173	40 Added 12.05%	372 $42,000
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $26,376 - $35,475	249 Added 300.0%	332 $42,000
Q3 2018 Nov 15, 2018	BUY	$211.18 - $274.49 $16,894 - $21,959	80 Added 2666.67%	83 $23,000
Q2 2018 Aug 13, 2018	SELL	$150.77 - $207.98 $904 - $1,247	-6 Reduced 66.67%	3 $1,000
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $1,247 - $1,643	9 New	9 $1,000

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Ligand Pharmaceuticals Inc Transaction History